Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Says FDA’s “Refuse To Accept” 510(k) Guidance Is Too Subjective

This article was originally published in The Gray Sheet

Executive Summary

Medical device firms generally support FDA’s “Refuse to Accept Policy for 510(k)s” draft guidance but have qualms with some of the new submission acceptance criteria the agency outlines.


Related Content

FDA Plans To Audit Its New 510(k) Refuse-To-Accept Program
FDA Finalizes 510(k), PMA, eCopy Guidances
Multiple MDUFA Policies In Transition Phase Until Jan. 1
Industry Praises PMA-Acceptance Draft Guidance, But Offers A Few Suggestions
FDA Aims To Reduce 510(k) Review Times With New Submission Acceptance Process





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts